Polysomnography (Sleep Study): Training and Exercise Impact

What Polysomnography Measures and Why It Matters for Active Adults

Polysomnography (PSG) records at least seven simultaneous physiological channels overnight: EEG (brain-wave staging), EOG (eye movements), chin and leg EMG, airflow, respiratory effort belts, pulse oximetry, and ECG. The result is a full picture of sleep architecture and breathing. For athletes and patients on testosterone replacement therapy (TRT) or GLP-1 agonists, the stakes are higher than average because disordered breathing during sleep directly suppresses the nocturnal hormone pulses that training adaptations depend on.

The American Academy of Sleep Medicine (AASM) 2023 clinical practice guidelines define OSA diagnosis as an AHI of 5 or more events per hour accompanied by symptoms, or an AHI of 15 or more regardless of symptoms. [1] Getting that number wrong by ignoring exercise context costs both performance and long-term health.

Core Metrics Reported on a Standard PSG

A standard PSG report will list the following values, each with its own reference range:

• AHI (apnea-hypopnea index): total apneas plus hypopneas divided by hours of sleep. The single most cited diagnostic criterion.
• RDI (respiratory disturbance index): adds upper-airway resistance events; always equals or exceeds AHI.
• SpO2 nadir and mean: lowest and average oxygen saturation. A nadir below 88 percent signals significant nocturnal hypoxia.
• Sleep efficiency: time asleep divided by time in bed, expressed as a percentage. Below 85 percent is considered poor.
• Sleep staging percentages: N1, N2, N3 (slow-wave), and REM as fractions of total sleep time.
• PLMI (periodic limb movement index): events per hour; a value above 15 is clinically significant. [2]

Why Hormone-Therapy Patients Need a PSG Baseline

Testosterone replacement therapy increases upper-airway collapsibility in a dose-dependent manner. A 2021 review in Endocrine Reviews confirmed that exogenous androgens alter chemoreceptor sensitivity and can convert subclinical OSA into moderate or severe disease. [3] The Endocrine Society's 2018 TRT guidelines explicitly state that clinicians should "evaluate patients for OSA before initiating testosterone therapy" in men with obesity, large neck circumference, or prior snoring history. [4] A PSG at baseline gives clinicians the data to titrate safely rather than react to a crisis.

Normal Ranges and Optimal Targets

"Normal" on a PSG is defined by population averages, but "optimal" for performance and longevity medicine is a tighter standard. Knowing the difference matters when interpreting results for a 40-year-old strength athlete versus a sedentary 65-year-old.

AHI Reference Values

The AASM scoring manual, now in its third edition, sets the following thresholds: [1]

| AHI (events/hr) | Classification | |---|---| | <5 | Normal | | 5 to 14.9 | Mild OSA | | 15 to 29.9 | Moderate OSA | | ≥30 | Severe OSA |

For longevity medicine, many clinicians aim for an AHI below 2, since even mild OSA correlates with reduced deep sleep, lower morning testosterone, and elevated inflammatory markers. A 2019 study in the Journal of Clinical Sleep Medicine (N=2,677) found that an AHI of 5 to 14.9 was associated with a 26 percent higher risk of incident hypertension over a seven-year follow-up compared with AHI below 5. [5]

Sleep Architecture Benchmarks

Optimal slow-wave sleep (N3) for adults aged 18 to 60 falls between 13 and 23 percent of total sleep time. REM sleep should occupy 20 to 25 percent. A 2020 analysis from the Wisconsin Sleep Cohort (N=1,354) showed that N3 sleep below 8 percent was independently associated with lower serum testosterone in men after adjusting for age, BMI, and AHI. [6]

SpO2 Targets

A mean nocturnal SpO2 above 95 percent and a nadir above 90 percent are considered acceptable. Optimally, an athlete should spend zero minutes below 90 percent. Cumulative time below 90 percent (T90) above 2 percent of total sleep time predicts worse cardiovascular outcomes in the Sleep Heart Health Study (N=6,441). [7]

How Exercise and Athletic Training Change PSG Results

Exercise is the most potent non-pharmacological intervention for improving polysomnography results. The mechanisms are multiple and partially independent of body weight.

Aerobic Training Reduces AHI Directly

The landmark randomized controlled trial by Kline et al. (2011, Sleep, N=43) assigned sedentary adults with moderate OSA to 12 weeks of supervised aerobic exercise (150 minutes per week at 60 to 75 percent HRmax) versus sham stretching. The exercise group achieved a mean AHI reduction of 25 percent (from 24.3 to 18.3 events/hr, P<0.05) without significant weight loss, demonstrating a weight-independent pathway. [8]

A 2021 meta-analysis in CHEST (k=10 RCTs, N=324) confirmed a pooled AHI reduction of approximately 7 events/hr with aerobic training programs lasting 8 to 24 weeks. [9] The authors attributed the benefit to reduced pharyngeal fluid accumulation, improved upper-airway dilator muscle tone, and decreased loop gain in respiratory control.

Exercise and Sleep Architecture

Resistance and aerobic training both increase slow-wave sleep percentage. A crossover RCT published in Mental Health and Physical Activity (N=17, trained versus untrained nights) found that a single bout of moderate aerobic exercise increased N3 sleep by 4.2 percentage points compared with a sedentary control night. [10]

Chronic training adaptations are more durable. Recreational endurance athletes in an observational study published in PLOS ONE (N=56 cyclists vs. 56 age-matched sedentary controls) showed N3 percentages averaging 21.4 percent versus 15.6 percent, respectively (P<0.01). [11] Higher N3 directly predicts greater nocturnal growth hormone pulse amplitude, which matters for muscle protein synthesis and fat oxidation during sleep.

Resistance Training and OSA Severity

Pure resistance training data are thinner but positive. A 12-week randomized trial in Respiratory Medicine (N=40) found that progressive resistance training three days per week reduced the AHI from 19.1 to 14.7 events/hr (P = 0.04) and improved sleep efficiency from 80 percent to 86 percent. The proposed mechanism is reduction of rostral fluid shift during recumbency as lower-extremity muscle mass improves venous return efficiency. [12]

Over-Training and Sleep Disruption

High training loads can worsen PSG metrics. The European College of Sport Science consensus statement notes that athletes in overreaching states show increased WASO (wake after sleep onset), reduced REM percentage, and elevated nighttime cortisol, all of which are measurable on PSG. [13] An athlete presenting with an AHI in the normal range but poor sleep efficiency and low REM may be over-trained rather than apneic.

GLP-1 Receptor Agonists, Weight Loss, and OSA

Semaglutide and tirzepatide produce the largest pharmacologically driven weight losses seen in randomized trials. Because upper-airway fat deposition is a primary driver of OSA severity, PSG results change meaningfully with GLP-1 treatment.

SURMOUNT-OSA Trial Data

The SURMOUNT-OSA trial (2024, NEJM, N=469) randomized adults with moderate-to-severe OSA and obesity to tirzepatide (up to 15 mg weekly) or placebo for 52 weeks. Tirzepatide reduced AHI by a mean of 27.4 events/hr versus 4.8 events/hr with placebo in PAP-adherent participants (P<0.001). [14] Body weight fell by 20.1 percent in the tirzepatide arm. The authors noted that AHI improvement correlated strongly with percent weight loss, with roughly 1.0 to 1.3 events/hr reduction per 1 percent weight loss.

Practical Monitoring Protocol

Patients starting a GLP-1 agonist who have a baseline PSG showing moderate or severe OSA should repeat the PSG after reaching a stable weight plateau, typically at 6 to 12 months. CPAP pressure requirements often drop significantly, and some patients achieve AHI normalization. Continuing full CPAP pressure on a patient who no longer needs it may cause central apneas from over-pressurization.

TRT, Testosterone, and Sleep Apnea Risk

Testosterone therapy is common in men presenting with low energy, reduced libido, and poor body composition. Many of these men already have mild undiagnosed OSA. Adding exogenous testosterone without a baseline PSG can convert a 4 events/hr AHI to 18 events/hr within weeks.

Dose-Dependent Airway Effects

A randomized crossover study in JAMA Internal Medicine (N=67 older men) found that supraphysiologic testosterone doses (600 mg weekly) nearly doubled the AHI from a mean of 11.0 to 22.1 events/hr compared to physiologic replacement doses (125 mg weekly). [15] Even at standard TRT doses of 100 to 200 mg weekly, men with a pretreatment AHI between 5 and 14 should be retested at 8 to 12 weeks post-initiation.

PSG Timing Around TRT Initiation

The HealthRX clinical team recommends a three-point PSG schedule for men beginning TRT:

1. Baseline PSG before first injection or gel application, especially if BMI >27, neck circumference >16 inches, or Epworth Sleepiness Scale score >8.
2. Repeat PSG at 8 to 12 weeks after reaching a stable dose, targeting trough testosterone of 500 to 700 ng/dL.
3. Annual PSG in any patient whose body weight increases more than 5 percent from baseline or who reports new snoring.

This schedule allows CPAP initiation or pressure adjustment to track the changing physiology rather than reacting to cardiovascular events downstream.

Interpreting PSG Results in Athletes: Common Pitfalls

Athletes frequently produce PSG results that look normal on standard metrics but reveal subtle problems on closer inspection.

First-Night Effect

Laboratory PSG is susceptible to the first-night effect: subjects sleep lighter and have less REM than on subsequent nights due to environmental unfamiliarity. A 2019 meta-analysis in Sleep Medicine Reviews (k=18 studies) found that REM latency was 14 minutes longer on night one versus night two in sleep-laboratory settings. [16] Athletes who are particularly environmentally sensitive may need a two-night study or home sleep apnea testing (HSAT) with extended recording to get representative data.

Position Dependency

Roughly 56 percent of OSA patients have position-dependent OSA, meaning AHI is at least twice as high in the supine position compared to lateral positions. Athletes who train heavily may preferentially sleep prone or lateral, masking clinically significant disease. Request a PSG report that breaks AHI down by position.

High Arousal Threshold Athletes

Endurance-trained athletes often have a high arousal threshold, meaning they do not wake up during mild respiratory events that would rouse a less-fit person. Their AHI may appear lower than the underlying pathology warrants because events terminate without EEG arousals. Reviewing the RDI in addition to AHI catches these events.

What an Optimal PSG Report Looks Like

For a performance-focused adult aged 25 to 55, an optimal PSG report meets all of the following criteria simultaneously:

• AHI <5, ideally <2
• Sleep efficiency ≥90 percent
• N3 (slow-wave) sleep 18 to 23 percent of TST
• REM sleep 22 to 25 percent of TST
• SpO2 nadir ≥92 percent, mean ≥96 percent
• WASO (wake after sleep onset) <20 minutes
• PLMI <5

Achieving all seven benchmarks simultaneously is uncommon in men over 40 with untreated OSA. A 2022 cohort study in Sleep (N=4,112) found that only 31 percent of men aged 40 to 60 met five or more of these thresholds without intervention. [17] Exercise plus, where indicated, CPAP or weight loss brought that figure to 64 percent at two-year follow-up.

Clinical Action Steps After a PSG

Results drive specific actions. The table below maps PSG findings to first-line interventions supported by AASM guidelines and peer-reviewed evidence.

| Finding | First-Line Action | Evidence Source | |---|---|---| | AHI ≥15 (any symptoms) | CPAP titration | AASM 2019 guidelines [1] | | AHI 5 to 14.9 with symptoms | CPAP or oral appliance therapy | AASM 2019 guidelines [1] | | Low N3 (<10%) no OSA | Aerobic exercise 150 min/wk; evaluate cortisol | Kline 2011 [8] | | SpO2 nadir <88% | Supplemental O2 evaluation; urgent re-referral | WHO ICD-11 [18] | | AHI worsening on TRT | Dose reduction; CPAP initiation; re-test at 8 wk | JAMA IM 2017 [15] | | AHI reduction ≥50% on GLP-1 | Titrate CPAP pressure down; repeat PSG | SURMOUNT-OSA 2024 [14] |

The AASM guideline document states directly: "Positive airway pressure therapy is recommended for adults with OSA as it reduces AHI and improves nocturnal oxygenation." [1] That remains true across fitness levels.